X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome ...
Hosted on MSN29m
Trump ignites controversy with Silk Road founder pardon
Donald Trump, the President of the USA, pardoned the founder of a website who was sentenced to double life imprisonment. This ...